Share

November 2017; 4 (6) ArticleOpen Access

Improving the antibody-based evaluation of autoimmune encephalitis

Lindsey McCracken, Junxian Zhang, Maxwell Greene, Anne Crivaro, Joyce Gonzalez, Malek Kamoun, Eric Lancaster
First published October 11, 2017, DOI: https://doi.org/10.1212/NXI.0000000000000404
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
2805

Share

Article Information

vol. 4 no. 6 e404
DOI: 
https://doi.org/10.1212/NXI.0000000000000404
PubMed: 
29075658
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received May 22, 2017
  • Accepted in final form August 22, 2017
  • First Published October 11, 2017.
Copyright & Usage: 
Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Author Disclosures

    1. Lindsey McCracken, MPH,
    2. Junxian Zhang, MD,
    3. Maxwell Greene, MD,
    4. Anne Crivaro, PhD,
    5. Joyce Gonzalez, BS, M(ASCP),
    6. Malek Kamoun, MD, PhD and
    7. Eric Lancaster, MD, PhD
  1. Lindsey McCracken, MPH,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Junxian Zhang, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Maxwell Greene, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. National Institute of Neurologic Diseases and Stroke, National Institutes of Health, grant R25 NS065745, 2014-2016.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Anne Crivaro, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Joyce Gonzalez, BS, M(ASCP),
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Malek Kamoun, MD, PhD and
    7. Scientific Advisory Boards:

    1. (1) Immucor (2) Omixon

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) One Lambda, travel paid, (2) Am. Soc. for Histocompatibility and Immunogenetics, travel paid

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NIH/NIDDK, UC4DK112217, Investigator, 4

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Eric Lancaster, MD, PhD
    8. Scientific Advisory Boards:

    1. (1) Advisory board for Grifols (2) Advisory board for Amgen (3) Advisory board for Janssen

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) Grifols Inc. Honoraria for teaching in courses to train their sales team about CIDP, and honoraria/travel to give a talk at the Peripheral nerve society meeting.

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Medimmune Inc., fees for expert consultation.

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. (1) Federal Vaccine Injury Compensation Program. Fees for expert review of cases.

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Consulted for Medimmune Inc. (2) Taught courses for Grifols, Inc. (3) Consulting for Amgen (4) Consulting for Janssen

    Research Support, Government Entities:

    1. (1) NINDS, K08 NS075142, PI, 2013-2017. (2) Grifols Inc. Investigator Sponsored Grant,

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. (1) Rogers Towers PA, 2015, medical legal consultation. (2) Orlando Health, 2015, medical legal consultation. (3) Wilson, Elser, Moskowitz, Edelman & Dicker LLP, medical legal consultation.

  1. From the Department of Neurology (L.M., J.Z., M.G., E.L.), and Department of Pathology (A.C., J.G., M.K.), University of Pennsylvania, Philadelphia.
  1. Correspondence to Dr. Lancaster: Eric.lancaster{at}uphs.upenn.edu
View Full Text

Article usage

Article usage: October 2017 to August 2023

AbstractFullPdfSource
Oct 201736416665Highwire
Oct 2017122016pmc
Nov 2017405258100Highwire
Nov 201770134154pmc
Dec 2017121534Highwire
Jan 201837031Highwire
Feb 201845840Highwire
Mar 2018625633Highwire
Apr 2018221033Highwire
Apr 2018376873pmc
May 2018214966Highwire
Jun 2018514644Highwire
Jun 2018154553pmc
Jul 2018411875Highwire
Aug 201815234Highwire
Aug 2018205756pmc
Sep 201815030Highwire
Oct 201815558Highwire
Nov 201827237Highwire
Dec 2018013421Highwire
Jan 2019112247Highwire
Feb 2019411257Highwire
Mar 201927942Highwire
Apr 201936234Highwire
May 2019134639Highwire
Jun 201983940Highwire
Jul 201956932Highwire
Aug 201954446Highwire
Sep 201985125Highwire
Oct 201975226Highwire
Nov 2019105035Highwire
Dec 20195299Highwire
Jan 202044013Highwire
Feb 202022813Highwire
Mar 202042914Highwire
Apr 202013524Highwire
May 202074232Highwire
Jun 202051413Highwire
Jul 202052527Highwire
Aug 202073130Highwire
Sep 2020103542Highwire
Oct 2020134855Highwire
Nov 202062745Highwire
Dec 202032429Highwire
Jan 2021142243Highwire
Feb 202192650Highwire
Mar 2021122129Highwire
Apr 2021132826Highwire
May 2021123632Highwire
Jun 202145643Highwire
Jul 202153857Highwire
Aug 202152432Highwire
Sep 202194440Highwire
Oct 202196348Highwire
Nov 202193040Highwire
Dec 202158734Highwire
Jan 202296635Highwire
Feb 202233422Highwire
Mar 202264936Highwire
Apr 2022105832Highwire
May 202263234Highwire
Jun 2022146137Highwire
Jul 2022314532Highwire
Aug 20221122724Highwire
Sep 20221021547Highwire
Oct 20221210229Highwire
Nov 2022149539Highwire
Dec 202243912Highwire
Jan 202385913Highwire
Feb 202354411Highwire
Mar 202372417Highwire
Apr 202361612Highwire
May 20231116418Highwire
Jun 202359714Highwire
Jul 202363923Highwire
Aug 202335322Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles